ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

Charles River Laboratories International, Inc. (CRL)

NYSE

$159.94

$-5.99

(-3.61%)

Charles River Laboratories International, Inc. (CRL) Live Price Chart

Page last updated: 2026-02-12 11:35:37

Key Market Data

Market Cap	$7.87B
Open	$166.66
High	$460.21
Low	$19.92
Previous Close	$165.98
Price Change	$-5.99
Percentage Change	-3.61%
Volume	3K

Charles River Laboratories International, Inc. (CRL) Stock Price Today

Charles River Laboratories International, Inc. (CRL) is currently trading at $159.94 as of 2026-02-12 11:35:37, reflecting a -3.61% move ($-5.99) from the previous close.

In the short term, the stock has returned -2,608.95% over the past four weeks. Over the last 12 months, Charles River Laboratories International, Inc. has recorded a +3.85% price change, indicating a stable performance relative to the broader market.

Charles River Laboratories International, Inc. (CRL) 7-Day Stock Price Changes

Over the past seven days, Charles River Laboratories International, Inc. has traded within a short-term range shaped by market sentiment in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector. During this period, the stock moved from its previous closing price of $184.89 to the latest recorded price of $159.94, reflecting an intraday change of -3.61%. Daily movements highlight shifts in trading volume (2,732), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, CRL has delivered a -2,608.95% return over the past month and a +3.85% change in the last 12 months, indicating a stable trend relative to its broader sector peers.

How to Buy Charles River Laboratories International, Inc. (CRL)

You can buy and trade CRL on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for CRL and Execute Your Trade

Open the trading page, enter CRL in the search bar, select the amount of CRL you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Charles River Laboratories International, Inc. (CRL)?

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Charles River Laboratories International, Inc. Information

Industry	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Employees	20,100
Sector	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Company Website	https://www.criver.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Charles River Laboratories International, Inc.?

The latest trading price for Charles River Laboratories International, Inc. (Common Stock) is $ 159.94, compared with a previous closing price of $ 165.98. That means the stock has moved -3.61% so far today. Intraday price updates and recent trading activity for CRL can be tracked on the live chart and quote section on this page.

2.Is Charles River Laboratories International, Inc. stock going up or down?

Looking at recent performances, CRL has returned -2,608.95% over the past month, +1.88% over the last six months and +3.85% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe stable price momentum for Charles River Laboratories International, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does CRL currently sit relative to its 52-week high and low?

In the most recent 52-week period, Charles River Laboratories International, Inc. has traded between a low of $ 91.86 and a high of $ 228.88. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether CRL is currently nearer the top or the bottom of its one-year trading band.

4.How is Charles River Laboratories International, Inc. classified by sector and industry?

Charles River Laboratories International, Inc. is classified in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector. In practice, this means Charles River Laboratories International, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing CRL’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector could influence Charles River Laboratories International, Inc.’s performance.

5.Where is Charles River Laboratories International, Inc. listed and how large is it by market value?

Charles River Laboratories International, Inc. is listed on the NYSE stock exchange in United States. Based on a market capitalization of $ 7.87B, the company is classified as a Mid-cap stock. Market cap gives a quick sense of Charles River Laboratories International, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does CRL's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -1.70 summarises how much profit Charles River Laboratories International, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Charles River Laboratories International, Inc.'s financial performance over time?

To follow Charles River Laboratories International, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how CRL is performing and how the market is responding.

8.When is Charles River Laboratories International, Inc. expected to report earnings?

Charles River Laboratories International, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for CRL, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Charles River Laboratories International, Inc.'s earnings reports?

Charles River Laboratories International, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether CRL is meeting, beating or missing expectations.

10.How can I stay informed about Charles River Laboratories International, Inc.'s results and guidance?

You can stay up to date on Charles River Laboratories International, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for CRL on this page helps you see how new information is being reflected in the stock.

11.Does Charles River Laboratories International, Inc. pay a regular cash dividend to its shareholders?

Charles River Laboratories International, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor CRL's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for CRL?

Based on the latest earnings data, CRL has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Charles River Laboratories International, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Charles River Laboratories International, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Charles River Laboratories International, Inc.?

Charles River Laboratories International, Inc. is a publicly traded company in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry within the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is CRL valued in terms of P/E ratio and EPS?

Charles River Laboratories International, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -1.70. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Charles River Laboratories International, Inc.'s earnings. Comparing CRL's P/E and EPS to those of other SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Charles River Laboratories International, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

AMC ENTERTAINMENT HOLDINGS, INC.

AMC

MMM

Top Gainers

Browse today's leading gainers in the US stock market

Peabody Energy Corporation

BTU

GWH

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

CRL-to-USD Calculator

Amount

CRL

USD

1 CRL = 159.935 USD